Tag: copper-64
Clarity secures large-scale manufacturing agreement for copper-64
Clarity Pharmaceuticals, an Australia-based clinical-stage radiopharmaceutical company, has announced a manufacturing supply agreement aimed at scaling up copper-64 production, as the company advances its radiopharmaceutical development program toward potential commercialisation.
Featured Article
The economic forces driving manufacturing’s next cycle
Australia’s manufacturing sector entered 2026 with improving momentum, but renewed global disruption is again testing resilience across the industry.
